Holen Sie sich die Stockscreener-App
3.155
1.45%
0.045
Schlusskurs vom Vortag:
$3.11
Offen:
$3.1344
24-Stunden-Volumen:
100.77K
Relative Volume:
0.37
Marktkapitalisierung:
$37.75M
Einnahmen:
$12,000
Nettoeinkommen (Verlust:
$-48.41M
KGV:
-0.1836
EPS:
-17.181
Netto-Cashflow:
$-19.99M
1W Leistung:
+7.31%
1M Leistung:
-14.96%
6M Leistung:
-63.48%
1J Leistung:
-77.26%
1-Tages-Spanne:
$3.11
$3.24
1-Wochen-Bereich:
$2.91
$3.24
52-Wochen-Spanne:
$2.49
$27.69
Incannex Healthcare Inc Stock (IXHL) Company Profile
Firmenname
Incannex Healthcare Inc
Sektor
Telefon
61 409 840 786
Adresse
8 CENTURY CIRCUIT, NORWEST NSW
Compare IXHL vs TAK, HLN, TEVA, ZTS, UTHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IXHL
Incannex Healthcare Inc
|
3.155 | 35.71M | 12,000 | -48.41M | -19.99M | -17.18 |
TAK
Takeda Pharmaceutical Co Adr
|
17.45 | 55.69B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
10.03 | 43.77B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
35.36 | 36.19B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
72.66 | 32.25B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
538.84 | 26.29B | 3.17B | 1.29B | 1.01B | 27.09 |
Incannex Healthcare Inc Aktie (IXHL) Neueste Nachrichten
Incannex Healthcare Inc. (IXHL) Stock Price | Live Quotes & Charts | NASDAQ - timothysykes.com
TradingKey - TradingKey
IXHL|Incannex Healthcare Inc|Price:2.985|Chg%:+0.035 - TradingKey
Incannex Healthcare Inc (IXHL) Institutional Confidence - TradingKey
Why Did IXHL Stock Tank Over 32% Today? - Stocktwits
Incannex Healthcare Inc (IXHL) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Incannex Healthcare Inc. (IXHL) Stock Price, News, Quote & History - Yahoo! Finance Canada
Incannex Healthcare Inc (IXHL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Incannex Healthcare Inc (IXHL) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Incannex Healthcare Inc. (IXHL) stock price, news, quote and history - Yahoo Finance Singapore
Incannex Healthcare Inc. Commences Participant Screening In Dreamzz Phase 2 Study Of IHL-42X For Obstructive Sleep Apnea - marketscreener.com
Incannex starts screening for Phase 2 study of IHL-42X to treat obstructive sleep apnea with FDA Fast Track status - Pluang
Incannex Commences Participant Screening in DReAMzz Phase 2 Study of IHL-42X for Obstructive Sleep Apnea - The Manila Times
Incannex Commences Screening in Phase 2 DReAMzz Study of IHL-42X for OSA - TradingView
Incannex starts screening patients in Phase 2 DReAMzz trial of IHL-42X for sleep apnea - Bitget
IXHL Stock Rips To Best Day In 5 Months: Nasdaq Compliance Back In Sight As FDA Catalyst For Sleep Apnea Drug Looms - Stocktwits
What Has Incannex (ASX:IHL) in Health Debate? - Kalkine Media
IXHL Q2 2026 Earnings: Significant EPS Miss Amid Operational ExpendituresFree Cash Flow Trends - dars.gov.et
Incannex Secures US Patent for Sleep Apnea Drug Candidate IHL-42X - Sleep Review
Incannex (IXHL) Secures U.S. Patent Grant in Obstructive Sleep Apnea for IHL-42X - Yahoo Finance
Incannex Healthcare Q2 2026 Earnings: Large EPS Miss but Stock Gains as Investors Focus on Pipeline ProgressBalance Sheet Strength - dars.gov.et
IXHL Q2 2026 Earnings: Significant EPS Miss as Pre-Revenue Biotech Ramps Up R&D SpendingCash Flow Report - dars.gov.et
Incannex Healthcare(IXHL) Stock Options Chain | Quotes & News - Moomoo
Incannex Healthcare (ASX:IHL): Why Is This Cannabis Innovator Back in Focus? - Kalkine Media
Price to earnings forward of Incannex Healthcare Inc. – NASDAQ:IXHL - TradingView
Price to book forward of Incannex Healthcare Inc. – NASDAQ:IXHL - TradingView
IXHL Q2 2026 Earnings: Significant EPS Miss Amid No Revenue, Yet Stock SurgesEarnings Yield Spread - dars.gov.et
Enterprise value to EBIT forward of Incannex Healthcare Inc. – NASDAQ:IXHL - TradingView
Price to sales forward of Incannex Healthcare Inc. – NASDAQ:IXHL - TradingView
Tranche Update on Incannex Healthcare Inc.'s Equity Buyback Plan announced on August 22, 2025. - marketscreener.com
Sleep Apnea Market Expected to Experience Accelerated Growth and Market Evolution by 2034 – DelveInsight | Apnimed, Eli Lilly, Incannex Healthcare, Axsome Therapeutics, Jazz Pharma, Bioprojet - Barchart.com
Incannex Healthcare (IXHL) Stock Forecast & Analyst Ratings - Moomoo
IXHL Forecast — Price Target — Prediction for 2027 - TradingView
Neuropsychiatric medicine reaches an inflexion point: regulation, science and the road to commercial reality - Manufacturing Chemist
Incannex Healthcare Inc. Actuals & Estimates (NASDAQ:IXHL) - TradingView
Incannex Healthcare Inc (IXHL) Valuation: PE, PB & Fair Value Analysis - TradingKey
A2DF4D Forecast — Price Target — Prediction for 2027 - TradingView
Incannex receives U.S. patent for sleep apnea drug IHL-42X By Investing.com - Investing.com South Africa
Incannex receives U.S. patent for sleep apnea drug IHL-42X - Investing.com
Incannex Healthcare Receives US Patent for IHL-42X in Obstructive Sleep Apnea - marketscreener.com
Incannex Secures U.S. Patent Grant for IHL-42X in Obstructive Sleep Apnea - The Manila Times
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Incannex's sleep apnea drug gets U.S. patent protection to 2040 - Stock Titan
Incannex (IXHL) secures long-dated U.S. patent for IHL-42X sleep apnoea therapy - Stock Titan
Incannex Healthcare Inc (IXHL) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Incannex Healthcare Inc (IXHL) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Why Is Incannex (ASX:IHL) Emerging as a Clinical Cannabis Story? - Kalkine Media
Incannex Healthcare Inc (IXHL) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Finanzdaten der Incannex Healthcare Inc-Aktie (IXHL)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.65%
8.60%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):